Partner Content Partner Content Using SDTM, ADaM, and SEND for Regulatory Submissions Using SDTM, ADaM, and SEND for Regulatory Submissions
News Bayer trial combines two top drugs for kidney disease Data from the CONFIDENCE trial shows the value of combining Bayer's Kerendia with an SGLT2 inhibitor to treat chronic kidney disease in diabetics.
